News
China delivers a win for Novo Nordisk on semaglutide IP
Novo Nordisk has been handed a crucial legal win by China's Supreme Court, which backed the validity of its patent on GLP-1 agonist semaglutide.
News
FDA declines to approve Corcept's rare disorder drug
As the celebrations for the end of 2025 gathered pace, the FDA delivered a year-end blow to Corcept by turning down its new Cushing's drug.
News
Vanda ends 40-year hiatus for new motion sickness drugs
The FDA has delivered some end-of-year cheer to Vanda Pharma after approving Nereus, its drug for the prevention of motion sickness.
News
Judge blocks HHS' 340B rebate pilot at 11th hour
A federal judge in the US has granted a restraining order that will stop the 340B rebate model from launching as planned on 1st January.
News
No Christmas present for Sanofi, as FDA turns down MS drug
FDA has turned down Sanofi's oral BTK inhibitor tolebrutinib for multiple sclerosis, despite suggesting earlier it would delay a decision until 2026.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
